Trial expands the eligible patient population and overall NeuVax clinical trial portfolio Recent patent allowance provides intellectual property protection for NeuVax in combination with Herceptin in any HER2/neu expressing cancer
PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced that data from the AKB-6548 development program will be
presented in two poster sessions at the upcoming American Society of
Nephrology (ASN) Kidney Week 2014 annual meeting in Philadelphia, PA
from November 11-16, 2014.
Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud
commerce solutions, today announced that the company will present at the
UBS Global Technology Conference
Tim Adams, Demandware Chief Financial Officer, will present on
Thursday, November 20 th at 8:30 a.m. PST at Cavallo Point,
The Lodge at the Golden Gate
An audio webcast of the presentation will be available on Demandware’s
investor relations website at http://investors.demandware.com .
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
present a corporate overview at the Stifel 2014 Healthcare Conference,
November 18, 2014 at 1:50 p.m. EST at The New York Palace Hotel in New
Company receives 'Big Data Competency' status and introduces enhanced solution for Amazon Redshift at AWS re:Invent in Las Vegas BURLINGTON, Massachusetts , November 11, 2014 /PRNewswire/ --
AES Eletropaulo markedly reduces call volume and lowers processing time for a fast ROI RA'ANANA, Israel , November 11, 2014 /PRNewswire/ --
NICE Systems (NASDAQ: NICE) today announced that AES Eletropaulo, a major power distributor in Brazil , has deployed NICE Real-Time Process Optimization in its contact center to improve operational efficiency, lower the number of repeat calls, and reduce average processing time.
MEF GEN14 — Transition
Networks , Inc., the fiber access technology expert, a wholly owned
subsidiary of Communications
Systems, Inc. (NASDAQ-GM: JCS), announced that it will be actively
participating in the MEF GEN14 event being held November 17-20 in
MEF GEN14 is a global Ethernet networking event for industry
professionals involved in all aspects of state-of-the-art innovations
powered by Carrier Ethernet, SDN, NFV and optical networking.
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company
focused on the discovery and development of G protein coupled receptor
(GPCR) biased ligands, today announced financial results for the quarter
ended September 30, 2014 and provided an update regarding its ongoing
Integration of Samsung's mobile innovations with the SAP Mobile Platform will help unlock new possibilities for developers and enterprise customers across key industries
SEOUL, South Korea , and BERLIN , Nov.
Leading U.S. toy and consumer products manufacturer, JAKKS
Pacific, Inc. (NASDAQ: JAKK), and Chinese entertainment and cultural
production industry group, Meisheng Culture & Creative Corp., Ltd,
(Stock Code: 002699.SZ) entered into a joint venture for the purpose of
providing certain JAKKS licensed and non-licensed toys and consumer
products to agreed upon territories of the People’s Republic of China.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.